GENEVA, Nov. 19 -- AVILAR THERAPEUTICS, INC. (400 Totten Pond Road, Suite 110Waltham, MA 02451) filed a patent application (PCT/US2025/028469) for "POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS COMPRISING ANTIBODIES FOR THE DEGRADATION OF TARGETED PROTEINS" on May 08, 2025. With publication no. WO/2025/235797, the details related to the patent application was published on Nov 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LIU, Hu (c/o Avilar Therapeutics, Inc.400 Totten Pond Road, Suite 110Waltham, MA 02451), GRAHAM, Philip, B. (c/o Avilar Therapeutics, Inc.400 Totten Pond Road, Sui...